Quick Answer
Arcus Biosciences, Inc. reported Shares Outstanding of 125.30 million shares for fiscal year 2025.
Arcus Biosciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 125.30M | +35.9% |
| 2024 | 92.20M | +22.1% |
| 2023 | 75.50M | +3.6% |
| 2022 | 72.90M | +3.0% |
| 2021 | 70.80M | +8.7% |
| 2020 | 65.11M | +41.8% |
| 2019 | 45.93M | +3.1% |
| 2018 | 44.54M | +988.7% |
| 2017 | 4.09M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 107.10M | +17.0% | +0.7% |
| June 30, 2025 | 106.40M | +16.5% | +0.5% |
| March 31, 2025 | 105.90M | +16.5% | +14.9% |
| December 31, 2024 | 92.20M | +22.1% | +0.8% |
| September 30, 2024 | 91.50M | +22.3% | +0.2% |
| June 30, 2024 | 91.30M | +22.6% | +0.4% |
| March 31, 2024 | 90.90M | +24.4% | +20.4% |
| December 31, 2023 | 75.50M | +3.6% | +0.9% |
- Arcus Biosciences, Inc. showed an increase of +35.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, Arcus Biosciences, Inc.’s shares outstanding has grown by 2962.9% (from 4.09 million shares to 125.30 million shares).
- The most recent figure is from Arcus Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: